Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00001177 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Premenstrual Syndrome and Premenstrual Dysphoria

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 325 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. 7 versions Re-verified since Apr 7, 2026, no change to tracked fieldsv319-v325
  2. Trial completed Enrollment target: estimated 1600 to confirmed 1569 · Site details revisedv318 Show 2 more changesShow less
    • Enrollment target: estimated 1600 to confirmed 1569
    • Site details revised
  3. 42 versions Re-verified since Jul 3, 2024, no change to tracked fieldsv276-v317
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to identify and describe the symptoms of premenstrual syndrome (PMS). Women who experience PMS symptoms will complete clinical interviews, self-rating scales, and evaluations of mood and endocrine function. A subgroup of women with severe PMS (Premenstrual Dysphoric Disorder or PMDD) will be offered additional research studies that focus on: 1) identifying the endocrine changes that may be responsible for changes in mood and behavior during the premenstrual period, 2) evaluating treatments for PMS symptoms, and/or 3) identifying genetic factors in women with and without PMS. Women with recurrent brief depression will also be recruited to serve as a comparison group.
Trial Details
NCT Number NCT00001177
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions Mood Disorder
Enrollment 1,569 participants
Start Date
Updated on ClinicalTrials.gov